All lobbying filings

TIBER CREEK GROUP

TIBER CREEK GROUP filed a Q1 report for BEONE MEDICINES USA, INC. (FKA BEIGENE USA, INC.) on April 20, 2025, reporting $70,000 in lobbying income.

Lobbying for BEONE MEDICINES USA, INC. (FKA BEIGENE USA, INC.) · Biopharmaceutical company.

All filings by TIBER CREEK GROUP · Everything BEONE MEDICINES USA, INC. (FKA BEIGENE USA, INC.) has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 20, 2025

Income

$70,000

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Issues related to implementation of drug pricing and reimbursement for prescription drugs in the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the implementation of the American Relief Act of 2025 (PL 118-158); Issues related to H.R. 946 - ORPHAN Cures Act.

Medicare/Medicaid

Issues related to drug pricing and reimbursement for prescription drugs related to the Inflation Reduction Act of 2022 (PL 117-169), Subtitle B (Part B and D drug pricing); Issues related to the implementation of the American Relief Act of 2025 (PL 118-158).

Bills named in this filing 1

H.R. 946
ORPHAN Cures Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.